MALIGNANT SOLID TUMOR
Clinical trials for MALIGNANT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT SOLID TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody combo shows promise against tough cancers
Disease control OngoingThis study tests an experimental antibody called GEN1042, alone or with the cancer drug pembrolizumab (with or without chemotherapy), in people with advanced solid tumors like lung, colon, melanoma, head and neck, or pancreatic cancer. The goal is to see if the treatment is safe …
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated May 07, 2026 18:38 UTC
-
New drug ASKB589 tested against advanced cancers
Disease control OngoingThis study tests a new drug called ASKB589 in people with advanced or metastatic solid tumors, especially stomach and pancreatic cancers. The goal is to check safety, side effects, and how well the drug works. About 199 participants will receive the drug to find the best dose and…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 26, 2026 19:35 UTC
-
New cancer drug combo tested in japanese patients
Disease control OngoingThis early-stage study tests a new drug called GEN1042, alone or with other cancer treatments, in Japanese adults with solid tumors. The main goal is to check safety and find the right dose. About 42 participants will be enrolled.
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Genmab • Aim: Disease control
Last updated Apr 24, 2026 16:18 UTC